Literature DB >> 25227504

Salinamide F, new depsipeptide antibiotic and inhibitor of bacterial RNA polymerase from a marine-derived Streptomyces sp.

Hossam M Hassan1, David Degen2, Kyoung Hwa Jang1, Richard H Ebright2, William Fenical1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25227504      PMCID: PMC4363298          DOI: 10.1038/ja.2014.122

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


× No keyword cloud information.
  10 in total

1.  A fluorescence-based assay for multisubunit DNA-dependent RNA polymerases.

Authors:  Peter Kuhlman; Heidi L Duff; Ashley Galant
Journal:  Anal Biochem       Date:  2004-01-15       Impact factor: 3.365

Review 2.  Discovery of novel metabolites from marine actinomycetes.

Authors:  Kin S Lam
Journal:  Curr Opin Microbiol       Date:  2006-05-03       Impact factor: 7.934

3.  Developing a new resource for drug discovery: marine actinomycete bacteria.

Authors:  William Fenical; Paul R Jensen
Journal:  Nat Chem Biol       Date:  2006-12       Impact factor: 15.040

4.  Phylogenetic diversity of gram-positive bacteria cultured from marine sediments.

Authors:  Erin A Gontang; William Fenical; Paul R Jensen
Journal:  Appl Environ Microbiol       Date:  2007-03-30       Impact factor: 4.792

5.  Nitropyrrolins A-E, cytotoxic farnesyl-α-nitropyrroles from a marine-derived bacterium within the actinomycete family Streptomycetaceae.

Authors:  Hak Cheol Kwon; Ana Paula D M Espindola; Jin-Soo Park; Alejandra Prieto-Davó; Mickea Rose; Paul R Jensen; William Fenical
Journal:  J Nat Prod       Date:  2010-11-23       Impact factor: 4.050

6.  Haemophilus test medium versus Mueller-Hinton broth with lysed horse blood for antimicrobial susceptibility testing of four bacterial species.

Authors:  A L Barry; M A Pfaller; P C Fuchs
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-07       Impact factor: 3.267

7.  Additive effect of tolC and rfa mutations on the hydrophobic barrier of the outer membrane of Escherichia coli K-12.

Authors:  J A Fralick; L L Burns-Keliher
Journal:  J Bacteriol       Date:  1994-10       Impact factor: 3.490

8.  Anthracimycin, a potent anthrax antibiotic from a marine-derived actinomycete.

Authors:  Kyoung Hwa Jang; Sang-Jip Nam; Jeffrey B Locke; Christopher A Kauffman; Deanna S Beatty; Lauren A Paul; William Fenical
Journal:  Angew Chem Int Ed Engl       Date:  2013-06-17       Impact factor: 15.336

Review 9.  New target for inhibition of bacterial RNA polymerase: 'switch region'.

Authors:  Aashish Srivastava; Meliza Talaue; Shuang Liu; David Degen; Richard Y Ebright; Elena Sineva; Anirban Chakraborty; Sergey Y Druzhinin; Sujoy Chatterjee; Jayanta Mukhopadhyay; Yon W Ebright; Alex Zozula; Juan Shen; Sonali Sengupta; Rui Rong Niedfeldt; Cai Xin; Takushi Kaneko; Herbert Irschik; Rolf Jansen; Stefano Donadio; Nancy Connell; Richard H Ebright
Journal:  Curr Opin Microbiol       Date:  2011-08-19       Impact factor: 7.934

10.  Transcription inhibition by the depsipeptide antibiotic salinamide A.

Authors:  David Degen; Yu Feng; Yu Zhang; Katherine Y Ebright; Yon W Ebright; Matthew Gigliotti; Hanif Vahedian-Movahed; Sukhendu Mandal; Meliza Talaue; Nancy Connell; Eddy Arnold; William Fenical; Richard H Ebright
Journal:  Elife       Date:  2014-04-30       Impact factor: 8.140

  10 in total
  15 in total

Review 1.  Metagenomics Approaches in Discovery and Development of New Bioactive Compounds from Marine Actinomycetes.

Authors:  Gyana Prakash Mahapatra; Surabhi Raman; Suman Nayak; Sushanto Gouda; Gitishree Das; Jayanta Kumar Patra
Journal:  Curr Microbiol       Date:  2019-05-08       Impact factor: 2.188

Review 2.  Marine natural product peptides with therapeutic potential: Chemistry, biosynthesis, and pharmacology.

Authors:  Vedanjali Gogineni; Mark T Hamann
Journal:  Biochim Biophys Acta Gen Subj       Date:  2017-08-24       Impact factor: 3.770

Review 3.  Marine Cyclic Peptides: Antimicrobial Activity and Synthetic Strategies.

Authors:  Ricardo Ribeiro; Eugénia Pinto; Carla Fernandes; Emília Sousa
Journal:  Mar Drugs       Date:  2022-06-15       Impact factor: 6.085

4.  Escaping mechanisms of ESKAPE pathogens from antibiotics and their targeting by natural compounds.

Authors:  Ragi Jadimurthy; Shilpa Borehalli Mayegowda; S Chandra Nayak; Chakrabhavi Dhananjaya Mohan; Kanchugarakoppal S Rangappa
Journal:  Biotechnol Rep (Amst)       Date:  2022-04-04

Review 5.  Antimicrobial compounds from marine actinomycetes.

Authors:  Cong Wang; Yuanyu Lu; Shugeng Cao
Journal:  Arch Pharm Res       Date:  2020-07-20       Impact factor: 4.946

6.  Thiol Probes To Detect Electrophilic Natural Products Based on Their Mechanism of Action.

Authors:  Gabriel Castro-Falcón; Dongyup Hahn; Daniela Reimer; Chambers C Hughes
Journal:  ACS Chem Biol       Date:  2016-06-28       Impact factor: 5.100

7.  Actinoquinolines A and B, anti-inflammatory quinoline alkaloids from a marine-derived Streptomyces sp., strain CNP975.

Authors:  Hossam M Hassan; Chollaratt Boonlarppradab; William Fenical
Journal:  J Antibiot (Tokyo)       Date:  2016-05-25       Impact factor: 2.649

8.  A Peptidyl-Transesterifying Type I Thioesterase in Salinamide Biosynthesis.

Authors:  Lauren Ray; Kazuya Yamanaka; Bradley S Moore
Journal:  Angew Chem Int Ed Engl       Date:  2015-11-10       Impact factor: 15.336

Review 9.  Peptides, Peptidomimetics, and Polypeptides from Marine Sources: A Wealth of Natural Sources for Pharmaceutical Applications.

Authors:  Rushikesh Sable; Pravin Parajuli; Seetharama Jois
Journal:  Mar Drugs       Date:  2017-04-22       Impact factor: 5.118

Review 10.  Marine Pharmacology in 2014-2015: Marine Compounds with Antibacterial, Antidiabetic, Antifungal, Anti-Inflammatory, Antiprotozoal, Antituberculosis, Antiviral, and Anthelmintic Activities; Affecting the Immune and Nervous Systems, and Other Miscellaneous Mechanisms of Action.

Authors:  Alejandro M S Mayer; Aimee J Guerrero; Abimael D Rodríguez; Orazio Taglialatela-Scafati; Fumiaki Nakamura; Nobuhiro Fusetani
Journal:  Mar Drugs       Date:  2019-12-19       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.